Title : Use of midostaurin in mixed phenotype acute leukemia with FLT3 mutation: A case series.

Pub. Date : 2022 Feb

PMID : 34653270






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Use of midostaurin in mixed phenotype acute leukemia with FLT3 mutation: A case series. midostaurin fms related receptor tyrosine kinase 3 Homo sapiens
2 Regarding FLT3-positive MPAL, only one case treated with midostaurin has been published to date. midostaurin fms related receptor tyrosine kinase 3 Homo sapiens
3 Here, we report the successful use of midostaurin to treat three FLT3-positive MPAL T/myeloid and B/myeloid patients. midostaurin fms related receptor tyrosine kinase 3 Homo sapiens
4 These results suggest that the addition of midostaurin during induction and consolidation therapy may represent a treatment option for FLT3-positive MPAL. midostaurin fms related receptor tyrosine kinase 3 Homo sapiens